John Rex
Editor-in-Chief at AMR.Solutions
Antibiotic developer & sender of occasional AMR newsletters. Antibiotics are the #FireExtinguishersOfMedicine! 💊🧯⚕️ #StopSuperbugs #AMRSOS
Articles
-
2 days ago |
amr.solutions | John Rex
John’s Top Recurring MeetingsVirtual meetings are easy to attend, but regular attendance at annual in-person events is the key to building your network and gaining deeper insight. My personal favorites for such in-person meetings are below. Of particular value for developers are BEAM’s AMR Conference and GAMRIC (formerly, the ESCMID-ASM conference series). Hope to see you there!1-3 Oct 2025 GAMRIC, the Global AMR Innovators Conference (London, UK).
-
3 days ago |
flipboard.com | John Rex
Do These 5 Things to Make People Trust You, According to a Stanford ExpertRobert Siegel is a Stanford lecturer and a VC who’s spent 16 years helping to launch startups. Here’s his advice. We don’t often use the word “trust” when we talk about leadership skills. But every entrepreneur and business leader needs trust to succeed. You need employees to trust you, if they’re …
-
1 week ago |
amr.solutions | John Rex
Dear All (unapologetically wonkish … very important material!), Let’s set the scene today by considering two quotes: Prosaic: “The successful treatment of patients with cancer has long depended on the capacity to manage infectious complications.” (Shropshire 2025, cited below) Blunt translation: “Your cancer will be controlled, but then you may die of infection.” (Abdul Ghafur, quoted from a 2019 podcast entitled “Superbugs Force a Deadly Choice for Cancer Patients”) In short, it is entirely...
-
2 weeks ago |
amr.solutions | John Rex
Dear All (wonkish alert … lots of details here … take your time and absorb it all!),I’ve written several times about the concept of DTR, or Difficult-to-Treat resistance, that was proposed in 2018 by Kadri et al. Today we will consider an important update from Kadri and colleagues in which the idea of DTR is adjusted to consider the implications of limited antibiotic access.
-
2 weeks ago |
webdisk.amr.solutions | John Rex
Dear All (wonkish alert … lots of details here … take your time and absorb it all!),I’ve written several times about the concept of DTR, or Difficult-to-Treat resistance, that was proposed in 2018 by Kadri et al. Today we will consider an important update from Kadri and colleagues in which the idea of DTR is adjusted to consider the implications of limited antibiotic access.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 2K
- Tweets
- 871
- DMs Open
- No
For #WAAW24, I ask you to take a moment to celebrate the @WHO Task Force of AMR Survivors. @purdiedad73 and @ellabalasa1 joined me to share their stories and details of their work so far. Listen now! https://t.co/tuHUb2MwNM #StopSuperbugs #AMRSOS⚕️ #FireExtinguishersOfMedicine
RT @IneosOxford: Today is the start of World AMR Awareness Week #WAAW This year's theme is 'Educate. Advocate. Act Now.' Throughout the we…
RT @CDC_AR: #AntimicrobialResistance (AR) is estimated to kill more than 1 million globally each year. Preventing infections in the first p…